Rehospitalization of Postpartum Depression and Psychosis After Electroconvulsive Therapy: A Population-Based Study With a Matched Control Group

The Journal of ECT
Ida RönnqvistAxel Nordenskjöld

Abstract

Electroconvulsive therapy (ECT) is used in some cases of postpartum depression (PPD) and postpartum psychosis (PPP). The risk of relapse for PPD and PPP after ECT is unknown. This study compared the relapse rate after ECT between women who had been treated for PPD and/or PPP and women who had been treated for depression and/or psychosis outside the postpartum period. The Swedish National Quality Register for ECT and the Swedish National Patient Register were used to identify women with PPD and/or PPP who had been treated with ECT within 6 months after delivery. For each case, a control (treated with ECT but not postpartum) patient was also selected. A Kaplan-Meier estimator was used to calculate the relapse rate (defined as rehospitalization or suicide) after ECT. Cox regression was used to identify variables associated with relapse. A total of 180 patients were included in each group. The proportions of patients who suffered relapse after 6 months, 1 year, and 2 years were 28%, 31%, and 40% for the postpartum group and 39%, 50%, and 55% for the nonpostpartum group. Treatment with benzodiazepines, several previous psychiatric admissions, and the absence of improvement after ECT were associated with relapse. The risk of relapse ...Continue Reading

References

Sep 1, 1991·Archives of General Psychiatry·M W O'HaraE J Wright
Nov 1, 2003·BMJ : British Medical Journal·Victoria Hendrick
Sep 8, 2004·Archives of General Psychiatry·Atif RahmanRichard Harrington
Mar 16, 2007·Maternal & Child Nutrition·Robert C Stewart
Feb 4, 2009·Archives of General Psychiatry·Trine Munk-OlsenPreben Bo Mortensen
Sep 8, 2010·Archives of Pediatrics & Adolescent Medicine·Shreya DavéIrwin Nazareth
Jun 11, 2011·BMC Public Health·Jonas F LudvigssonPetra Otterblad Olausson
Feb 15, 2012·The Journal of ECT·Amanda Focht, Charles H Kellner
May 9, 2012·Nordic Journal of Psychiatry·Anna NagerKristina Sundquist
Dec 12, 2012·Journal of Affective Disorders·Florian HardeveldAartjan T F Beekman
Feb 12, 2013·Annual Review of Clinical Psychology·Michael W O'Hara, Jennifer E McCabe
Jun 19, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ana JelovacDeclan M McLoughlin
Aug 20, 2016·International Journal of Psychiatry in Clinical Practice·Takahito UchidaMasaru Mimura
Sep 10, 2016·The American Journal of Psychiatry·Veerle BerginkKatherine L Wisner
Dec 14, 2016·The New England Journal of Medicine·Donna E Stewart, Simone Vigod
Mar 27, 2018·Acta Psychiatrica Scandinavica·M Ten HaveB W J H Penninx

❮ Previous
Next ❯

Citations

Mar 17, 2020·Expert Review of Neurotherapeutics·Verinder SharmaSapna Sharma
Dec 16, 2020·Psychiatry Investigation·Mi Jin ParkHong Jin Jeon

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies
pharmacotherapy

Software Mentioned

SPSS Statistics
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.